Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. (Q51777950)

12 April 2018

title

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. (English)

1 reference

12 April 2018

0 references

1 reference

adenosquamous carcinoma

1 reference

adenosquamous pancreas carcinoma

inferred from title

1 reference

7

Ralph H Hruban

1 reference

12 April 2018

Charles J Yeo

6

object named as

Charles J Yeo

1 reference

12 April 2018

author name string

Jonathan R Brody

1

1 reference

12 April 2018

Christina L Costantino

2

1 reference

12 April 2018

Magdalena Potoczek

3

1 reference

12 April 2018

Joseph Cozzitorto

4

1 reference

12 April 2018

Peter McCue

5

1 reference

12 April 2018

Agnieszka K Witkiewicz

8

1 reference

12 April 2018

publication date

6 March 2009

1 reference

12 April 2018

published in

Modern Pathology

1 reference

12 April 2018

volume

22

1 reference

12 April 2018

page(s)

651-659

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.15

exact match

0 references

cites work

Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Adenosquamous carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Adenosquamous Carcinoma Of The Pancreas: A Clinicopathologic Series Of 25 Cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Overexpression of p53 protein in adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

The epidermal growth factor receptor in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

EGF-ERBB signalling: towards the systems level

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Targeting the HER-kinase axis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

DeltaNp63 expression in pancreas and pancreatic neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

10.1038/MODPATHOL.2009.15

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

19270646

1 reference

12 April 2018